Insulin-related pathways (cluster I) are also associated with the susceptibility to cause physiologic cardiac hypertrophy by over-expression of insulin-like growth factor 1 (IGF-1) and insulin-like growth factor 1 receptor (IGF1R), via the PI3K (p110alpha) pathway [46], [47]. The gene discussed is IGF1; the disease is cardiac hypertrophy.